Examkin

Soru

Zorluk: OrtaOrdering Laboratory Tests

A patient in the cardiac intensive care unit is noted to have a rapidly declining platelet count on morning laboratories. He was admitted 6 days prior for a non-ST-segment elevation myocardial infarction, for which he underwent percutaneous coronary intervention and received continuous unfractionated heparin infusion for 48 hours. Currently, he is on subcutaneous heparin for deep vein thrombosis prophylaxis. His admission platelet count was 240,000/mm3240,000/\text{mm}^3. Today's routine complete blood count reveals a platelet count of 95,000/mm395,000/\text{mm}^3. The patient is asymptomatic, with no petechiae, ecchymoses, or active bleeding. Hemoglobin is 13.5 g/dL13.5 \text{ g/dL} and leukocyte count is 7,500/mm37,500/\text{mm}^3. Vital signs are stable. Which of the following is the most appropriate next step in laboratory evaluation?

  1. A
    Functional serotonin release assay
  2. B
    Peripheral blood smear for schistocyte evaluation
  3. Immunoassay for platelet factor 4-heparin antibodiesCevap
  4. D
    Measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen
  5. E
    Bone marrow aspiration and biopsy

Cevap

The most appropriate next step in laboratory evaluation is an immunoassay for platelet factor 4-heparin antibodies.
The correct answer is the immunoassay for platelet factor 4-heparin antibodies. This patient presents with a classic clinical picture for heparin-induced thrombocytopenia (HIT): a relative platelet count drop of greater than 50% occurring 5 to 10 days after the initial exposure to unfractionated heparin. He has a high pre-test probability based on the 4T scoring system (thrombocytopenia severity, timing, thrombosis, and absence of other causes). For patients with intermediate to high clinical suspicion of HIT, the most appropriate next step in laboratory evaluation is a screening immunoassay (ELISA) targeting the PF4-heparin antibody complex. This test provides rapid results and has extremely high sensitivity, effectively ruling out HIT if the result is negative.

Adım Adım Çözüm

1
Analyze the clinical presentation and timing of thrombocytopenia
The patient developed a greater than 50% drop in platelets exactly 6 days after heparin initiation, without bleeding, which strongly correlates with heparin-induced thrombocytopenia (HIT).
Identifying the clinical syndrome and its timeline is crucial to determining the pre-test probability (using the 4T score) and selecting the appropriate diagnostic pathway.
2
Determine the diagnostic algorithm for suspected HIT
Clinical guidelines recommend initial laboratory screening with a highly sensitive immunoassay, followed by a confirmatory functional assay only if the screen is positive.
Using a highly sensitive screening test first avoids the delay and expense of immediate confirmatory testing, which is reserved for positive screening results.
3
Select the correct initial laboratory test
The enzyme-linked immunosorbent assay (ELISA) for PF4-heparin antibodies is the indicated initial test.
This test provides rapid, highly sensitive screening to quickly evaluate for the presence of the pathogenic antibodies causing HIT.

Anahtar Kavram

The initial laboratory evaluation for suspected heparin-induced thrombocytopenia (HIT) is a highly sensitive immunoassay for platelet factor 4 (PF4)-heparin antibodies, followed by a confirmatory functional assay if positive.
Bu soruyu puanla

Konular

Ordering Laboratory Tests

Bu konudan daha fazla soru